Age-related macular degeneration (AMD) is a progressive disorder of the retina in older adults. Dry AMD, characterised by deposits in the fundus, does not cause significant vision loss. But if it progresses to advanced AMD, it can cause severe vision loss if left untreated. Laser therapy, which itself can damage the retina, was standard therapy during 1980 and 90s. However, a class of drugs that inhibit vascular endothelial growth factor has revolutionised outcomes for many patients.